Method: Products: Products: Surfactant-free dentifrice (REMBRANDT® GENTLE WHITE), pyrophosphate and cocamidopropyl betaine-containing dentifrice (REMBRANDT® INTENSE STAIN®) and pyrophosphate and sodium lauryl sulfate-containing dentifrice (Crest® 3D White). Each product was exposed to duplicate tissues at four different exposure times. The tissue viability was determined by the enzymatic reduction of MTT (3[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide). The toxicity of each product was evaluated on the basis of the relative tissue viability versus exposure time. The duration of exposure resulting in a 50% decrease in MTT conversion in the product-treated EpiOral™ tissues was determined (ET50). Longer ET50 values indicate reduced irritation potential.
Result:
Product |
ET50 (hours) |
REMBRANDT® GENTLE WHITE |
> 24 |
REMBRANDT® INTENSE STAIN® |
12.8 |
Crest® 3D White |
5.1 |
Method Control (1% Triton X) |
0.9 |
Conclusion: The data showed that the ET50 values for both REMBRANDT® dentifrices were longer compared to Crest® 3D White dentifrice, thus indicating their reduced irritation potential as assessed by exposure to the in-vitro model and testing platform used in our study. Both surfactant-containing dentifrices (REMBRANDT® INTENSE STAIN® and Crest® 3D White) show increased irritation potential compared to the surfactant-free dentifrice (REMBRANDT® GENTLE WHITE), however the irritation potential is reduced for the dentifrice containing cocamidopropyl betaine as a surfactant instead of sodium lauryl sulfate, which is a known irritant. These results showed that the in vitro testing method used is a reliable pre-screening tool for the assessment of oral irritation potential of dentifrices.